Karen Cashmere
About Karen Cashmere
Karen Cashmere Chief Commercial Officer
Karen Cashmere currently holds the position of Chief Commercial Officer. With an extensive background in business planning and execution for both biopharmaceutical and medical device companies, she brings over 25 years of industry experience. Her role involves overseeing commercial strategies, ensuring business growth, and leading marketing and sales efforts.
Karen Cashmere Experience in Biopharmaceuticals
Karen Cashmere has a robust career in the biopharmaceutical and medical device sectors. She formerly led the Marketing Communications function at Mako Surgical Corporation. During her tenure, she worked on creating awareness and driving sales of robotic arm systems and implants for partial knee and total hip arthroplasty. Her efforts contributed to the company's substantial unit sales and revenue growth, which eventually led to a $1.65 Billion acquisition by Stryker.
Karen Cashmere Leadership at Auxilium Pharmaceuticals
At Auxilium Pharmaceuticals, Karen served as the Senior Vice President for New Product Marketing. She was instrumental in creating the New Product Marketing Business Unit, focusing primarily on men's health and orphan indications. Her leadership in the strategic partnership review process led to the out-licensing of European rights of Xiaflex to Pfizer.
Karen Cashmere's Strategic Roles at Leading Companies
Karen Cashmere has held significant strategic marketing positions throughout her career. As the Senior Director of Marketing at Andrx Laboratories, she was responsible for a newly created business unit that focused on the commercialization of pipeline products for men's health. She has also held strategic marketing roles at companies such as Noven, Serono, and Abbott, contributing to their business growth and product development initiatives.